Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment (Q33736180)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment |
scientific article |
Statements
1 reference
Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment (English)
1 reference
Dawn L Hershman
1 reference
Donald J McMahon
1 reference
Katherine D Crew
1 reference
Theresa Shao
1 reference
Serge Cremers
1 reference
Lois Brafman
1 reference
Danielle Awad
1 reference
Elizabeth Shane
1 reference
18 December 2009
1 reference
1 reference
95
1 reference
559-566
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference